OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 42 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.89 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $35,000 | -77.1% | 165,770 | +39.6% | 0.00% | – |
| Q4 2017 | $153,000 | -70.3% | 118,770 | -51.1% | 0.00% | -100.0% |
| Q3 2017 | $515,000 | -24.3% | 242,869 | +3.5% | 0.00% | 0.0% |
| Q2 2017 | $680,000 | -15.8% | 234,543 | -0.1% | 0.00% | 0.0% |
| Q1 2017 | $808,000 | +80.0% | 234,740 | -9.1% | 0.00% | – |
| Q4 2016 | $449,000 | -48.8% | 258,352 | -2.1% | 0.00% | -100.0% |
| Q3 2016 | $877,000 | – | 263,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 622,013 | $2,140,000 | 0.92% |
| Foresite Capital Management III, LLC | 380,530 | $1,309,000 | 0.50% |
| BVF INC/IL | 734,976 | $2,528,000 | 0.43% |
| Old West Investment Management, LLC | 206,687 | $711,000 | 0.38% |
| Telemetry Investments, L.L.C. | 88,269 | $304,000 | 0.14% |
| EcoR1 Capital, LLC | 117,726 | $405,000 | 0.10% |
| Baupost Group | 2,226,839 | $7,660,000 | 0.09% |
| Rhenman & Partners Asset Management AB | 120,000 | $413,000 | 0.06% |
| GLG LLC | 250,172 | $861,000 | 0.05% |
| NEA Management Company, LLC | 370,900 | $1,276,000 | 0.04% |